4-(6,7-dimethoxyquinolin-4-yl)oxyaniline
CAS No. 190728-25-7
4-(6,7-dimethoxyquinolin-4-yl)oxyaniline( 4-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine | BenzenaMine, 4-[(6,7-diMethoxy-4-quinolinyl)oxy]- )
Catalog No. M28615 CAS No. 190728-25-7
4-(6,7-dimethoxyquinolin-4-yl)oxyanilines is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
10MG | 68 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 173 | In Stock |
|
100MG | 258 | In Stock |
|
200MG | 388 | In Stock |
|
500MG | 642 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-(6,7-dimethoxyquinolin-4-yl)oxyaniline
-
NoteResearch use only, not for human use.
-
Brief Description4-(6,7-dimethoxyquinolin-4-yl)oxyanilines is a chemical compound.
-
Description4-(6,7-dimethoxyquinolin-4-yl)oxyanilines is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms4-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine | BenzenaMine, 4-[(6,7-diMethoxy-4-quinolinyl)oxy]-
-
PathwayOthers
-
TargetOther Targets
-
RecptorTLR7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number190728-25-7
-
Formula Weight296.32
-
Molecular FormulaC17H16N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc(cc1c(Oc(cc2)ccc2N)ccnc1c1)c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Saroa R, et al. Efficacy of TLR7 agonistic imidazoquinoline as immunochemotherapeutic agent against P. Berghei ANKA infected rodent host. Bioorg Med Chem Lett. 2019 May 1;29(9):1099-1105.
molnova catalog
related products
-
72'-dihydroxy-3'4'-d...
72'-dihydroxy-3'4'-dimethoxyisoflavane-7-O-glucoside is a natural product from Astragalus membranaceus.
-
BMS-927711
BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
-
Neoruscogenin
Neoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.